MDxHealth (MXDHF) Stock Price, News & Analysis

Company Overview

MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, Europe, and internationally. Its novel prostate cancer genomic testing solutions are SelectMDx, a non-invasive urine test; and ConfirmMDx, an epigenetic test, which provide physicians with a clinical pathway to identify clinically prostate cancer while minimizing the use of invasive procedures that are prone to complications. The company was formerly known as OncoMethylome Sciences SA and changed its name to MDxHealth SA in October 2010. MDxHealth SA was incorporated in 2003 and is headquartered in Herstal, Belgium.

Key Stats

• Today's Range: N/A
• 50-Day Range: $0.25 to $0.25
• 52-Week Range: N/A
• Volume: 300 shs
• Average Volume: 1,000 shs
• Market Capitalization: $3.90 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

MXDHF Stock Analysis - Frequently Asked Questions

How do I buy shares of MDxHealth?

Shares of MXDHF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Company Calendar

• Today: 1/14/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Private households
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:MXDHF
• Previous Symbol: NASDAQ:MXDHF
• CUSIP: N/A
• CIK: N/A
• Web: www.mdxhealth.com
• Phone: (324) 257-7071
• Fax: 32042597875
• Employees: 252
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: 1.45
• Current Ratio: 1.25
• Quick Ratio: 1.19

Sales & Book Value

• Annual Sales: $37.05 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $0.60 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 15,597,000
• Free Float: 15,332,000
• Market Cap: $3.90 million
• Optionable: Not Optionable
• Beta: 1.46